Literature DB >> 11736980

Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer.

L Bergkvist1, J Frisell, G Liljegren, F Celebioglu, S Damm, M Thörn.   

Abstract

BACKGROUND: Sentinel node biopsy has recently evolved as a means of staging the axilla in breast cancer with minimal surgical trauma. The aim of this prospective multicentre study was to identify factors that influenced the detection and false-negative rates during the learning phase.
METHODS: Data on all 498 sentinel node biopsies performed between August 1997 and December 1999 in Sweden were collected.
RESULTS: A sentinel node was found in 450 patients (90 per cent). Preoperative scintigraphy visualized 83 per cent of all sentinel nodes. The detection rate was higher with same-day injection of tracer than with injection the day before (96 versus 86 per cent; P < 0.01). Dye injected less than 5 min or more than 30 min before the start of the operation lowered the detection rate (less than 60 per cent versus more than 65 per cent; P = 0.02). The detection rate varied from 61 to 100 per cent between surgeons. The false-negative rate was 11 per cent. The presence of multiple tumour foci and a high S-phase fraction increased the risk of a false-negative sentinel node, whereas the number of operations performed by each surgeon was less important.
CONCLUSION: Training of the individual surgeon influenced the detection rate, as did timing of tracer and dye injection. The false-negative rate seemed to be related to biological factors.

Entities:  

Mesh:

Year:  2001        PMID: 11736980     DOI: 10.1046/j.0007-1323.2001.01948.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

Review 1.  Sentinel lymph node mapping for primary breast cancer.

Authors:  Lori L Wilson; Armando E Giuliano
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 2.  Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.

Authors:  Wolfgang Janni; Thorsten Kühn; Lukas Schwentner; Rolf Kreienberg; Tanja Fehm; Achim Wöckel
Journal:  Dtsch Arztebl Int       Date:  2014-04-04       Impact factor: 5.594

Review 3.  Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?

Authors:  Gilles Houvenaeghel; Agnès Tallet; Aurélie Jalaguier-Coudray; Monique Cohen; Marie Bannier; Camille Jauffret-Fara; Eric Lambaudie
Journal:  World J Clin Oncol       Date:  2016-04-10

4.  Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?

Authors:  A Bembenek; J Fischer; H Albrecht; E Kemnitz; S Gretschel; U Schneider; S Dresel; P M Schlag
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

5.  Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Authors:  Katherine E Posther; Linda M McCall; Peter W Blumencranz; William E Burak; Peter D Beitsch; Nora M Hansen; Monica Morrow; Lee G Wilke; James E Herndon; Kelly K Hunt; Armando E Giuliano
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

6.  Is breast cancer the same disease in Asian and Western countries?

Authors:  Stanley P L Leong; Zhen-Zhou Shen; Tse-Jia Liu; Gaurav Agarwal; Tomoo Tajima; Nam-Sun Paik; Kerstin Sandelin; Anna Derossis; Hiram Cody; William D Foulkes
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

7.  Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green.

Authors:  Kei Aoyama; Takako Kamio; Tetsuya Ohchi; Masako Nishizawa; Shingo Kameoka
Journal:  World J Surg Oncol       Date:  2011-12-02       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.